POSB100 Cost-Comparison Model of Brolucizumab for the Treatment of Age-Related Macular Degeneration
Jan 1, 2022, 00:00 AM
10.1016/j.jval.2021.11.373
https://www.valueinhealthjournal.com/article/S1098-3015(21)02168-9/fulltext
Section Title :
Section Order :
11154
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02168-9&doi=10.1016/j.jval.2021.11.373